← Leaderboards
Pei Zhou
Duke University
$18,119,545
Attributed
$24,104,085
Total exposure
15
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,104,085 · 15
By mechanism
R01$23,350,546 · 13
R56$393,419 · 1
R21$360,120 · 1
Top collaborators
- Jen-Tsan Ashley Chi6 shared
- Jiyong Hong5 shared
- Robert A Nicholas5 shared
- Raphael H. Valdivia5 shared
- Tai-Ping Sun4 shared
Most similar at Duke University
Same institution · by research overlap
- Jen-Tsan Ashley Chi$7,491,502
- Raphael H. Valdivia$16,950,167
- Jiyong Hong$5,518,476
- Christian R Raetz$13,955,306
Others in their field
Top investigators on “Complex”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$385,971,304
- Chanza Baytop · Westat, Inc.$271,217,917
- David R. Weir · University Of Michigan At Ann Arbor$186,776,551
- Barton F Haynes · Duke University$162,931,717
Research focus
ComplexStructurePublic Health RelevanceInsightBiochemicalAnabolismBacteriaResistanceEnzymesBasePathogenMolecularProteinsGenesPathway InteractionsMediatingGeneticLeadEscherichia ColiOrganismCellsLipid AGram-Negative BacteriaAntibiotics
Grant awards (58)
LpxH Inhibitors as Novel Therapeutics Against Multidrug-resistant Enterobacterales$747,763
R01 · FY2025 · AI · contact PI
Inhibiting Rev1-mediated translesion DNA synthesis for cancer therapy$521,760
R01 · FY2025 · CA
Structural and Functional Analysis of Nucleocytoplasmic Protein O-Glycosyltransferases in Plants$419,195
R01 · FY2025 · GM · contact PI
Mechanistic Insights into the Plant Disease Resistance Mediated by NPR1$365,892
R01 · FY2025 · GM · contact PI
Inhibiting Rev1-mediated translesion DNA synthesis for cancer therapy$521,760
R01 · FY2024 · CA
Structural and Functional Analysis of Nucleocytoplasmic Protein O-Glycosyltransferases in Plants$419,195
R01 · FY2024 · GM · contact PI
Mechanistic Insights into the Plant Disease Resistance Mediated by NPR1$365,983
R01 · FY2024 · GM · contact PI
Structural and Functional Analysis of Nucleocytoplasmic Protein O-Glycosyltransferases in Plants$249,565
R01 · FY2024 · GM · contact PI
Structural and Functional Analysis of Nucleocytoplasmic Protein O-Glycosyltransferases in Plants$419,195
R01 · FY2023 · GM · contact PI
Mechanistic Insights into the Plant Disease Resistance Mediated by NPR1$366,075
R01 · FY2023 · GM · contact PI
Mechanistic Insights into the Plant Disease Resistance Mediated by NPR1$224,429
R01 · FY2023 · GM · contact PI
Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens$458,280
R01 · FY2022 · AI · contact PI
Mechanistic Insights into the Plant Disease Resistance Mediated by NPR1$366,162
R01 · FY2022 · GM · contact PI
Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens$458,280
R01 · FY2021 · AI · contact PI
Biochemical and functional investigation of the novel enzymatic activities of MESH1$391,323
R01 · FY2021 · GM
Biochemical and functional investigation of the novel enzymatic activities of MESH1$375,495
R01 · FY2021 · GM
Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens$555,313
R01 · FY2020 · AI · contact PI
Structure-Function Analysis of Chlamydia Secretion Chaperones$517,940
R01 · FY2020 · AI
Biochemical and functional investigation of the novel enzymatic activities of MESH1$391,323
R01 · FY2020 · GM
Biochemical and functional investigation of the novel enzymatic activities of MESH1$70,500
R01 · FY2020 · GM
Structure-Function Analysis of Chlamydia Secretion Chaperones$517,940
R01 · FY2019 · AI
Biochemical and functional investigation of the novel enzymatic activities of MESH1$391,323
R01 · FY2019 · GM
Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens$387,505
R01 · FY2019 · AI · contact PI
Biochemistry and Structure of Lipid A Enzymes$301,171
R01 · FY2019 · GM · contact PI
Structure-Function Analysis of Chlamydia Secretion Chaperones$517,940
R01 · FY2018 · AI
Discovery and validation of broadly effective LpxH inhibitors as novel therapeutics against multi-drug resistant Gram-negative pathogens$393,419
R56 · FY2018 · AI · contact PI
Biochemical and functional investigation of the novel enzymatic activities of MESH1$388,934
R01 · FY2018 · GM
Biochemistry and Structure of Lipid A Enzymes$301,205
R01 · FY2018 · GM · contact PI
Structure-Function Analysis of Chlamydia Secretion Chaperones$517,940
R01 · FY2017 · AI
Biochemistry and Structure of Lipid A Enzymes$301,309
R01 · FY2017 · GM · contact PI
Structure-Function Analysis of Chlamydia Secretion Chaperones$517,940
R01 · FY2016 · AI
Biochemistry and Structure of Lipid A Enzymes$301,493
R01 · FY2016 · GM · contact PI
Targeting Rev1-mediated Translesion Synthesis for Cancer Therapy$162,654
R21 · FY2016 · CA · contact PI
LpxC inhibitors as a novel class of antibiotics against N. gonorrhoeae$715,619
R01 · FY2015 · AI · contact PI
Targeting Rev1-mediated Translesion Synthesis for Cancer Therapy$197,466
R21 · FY2015 · CA · contact PI
LpxC inhibitors as a novel class of antibiotics against N. gonorrhoeae$723,844
R01 · FY2014 · AI · contact PI
LpxC inhibitors as a novel class of antibiotics against N. gonorrhoeae$687,904
R01 · FY2013 · AI · contact PI
Biosynthesis And Function Of Lipopolysaccharides$630,142
R01 · FY2013 · GM · contact PI
LpxC inhibitors as a novel class of antibiotics against N. gonorrhoeae$741,665
R01 · FY2012 · AI · contact PI
Biosynthesis And Function Of Lipopolysaccharides$652,932
R01 · FY2012 · GM · contact PI
Lipid A Modification Systems in Gram-Negative Bacteria$382,239
R01 · FY2012 · GM · contact PI
Structural and Biochemical Studies of LpxC Inhibition$382,239
R01 · FY2012 · AI · contact PI
LpxC inhibitors as a novel class of antibiotics against N. gonorrhoeae$842,898
R01 · FY2011 · AI · contact PI
Biosynthesis And Function Of Lipopolysaccharides$652,865
R01 · FY2011 · GM · contact PI
Lipid A Modification Systems in Gram-Negative Bacteria$382,239
R01 · FY2011 · GM · contact PI
Structural and Biochemical Studies of LpxC Inhibition$382,239
R01 · FY2011 · AI · contact PI
Structural, Biochemical and Functional Studies of RNAPII CTD Interacting Proteins$305,791
R01 · FY2011 · GM · contact PI
Structural and Biochemical Studies of LpxC Inhibition$386,100
R01 · FY2010 · AI · contact PI
Structural, Biochemical and Functional Studies of RNAPII CTD Interacting Proteins$308,880
R01 · FY2010 · GM · contact PI
Structural and Biochemical Studies of LpxC Inhibition$390,000
R01 · FY2009 · AI · contact PI
Structural, Biochemical and Functional Studies of RNAPII CTD Interacting Proteins$312,000
R01 · FY2009 · GM · contact PI
Structural and Biochemical Studies of LpxC Inhibition$48,060
R01 · FY2009 · AI · contact PI
Structural and Biochemical Studies of LpxC Inhibition$390,000
R01 · FY2008 · AI · contact PI
Structural, Biochemical and Functional Studies of RNAPII CTD Interacting Proteins$312,000
R01 · FY2008 · GM · contact PI
Structure and Mechanism of LpxC in Lipid A Biosynthesis$300,762
R01 · FY2006 · AI · contact PI
Structure and Mechanism of LpxC in Lipid A Biosynthesis$308,000
R01 · FY2005 · AI
Structure and Mechanism of LpxC in Lipid A Biosynthesis$308,000
R01 · FY2004 · AI
Structure and Mechanism of LpxC in Lipid A Biosynthesis$154,000
R01 · FY2003 · AI